The article, "transcatheter mitral valve-in-valve explant: lessons learned", was reviewed.The article presented a case study of a 71-year-old male patient with pulmonary edema and decompensation heart failure.It was reported that on an unknown date, a 33mm epic valve was implanted.It was then reported 11 years post-procedure on an unknown date, the patient presented with acute severe mitral regurgitation and pulmonary edema.A decision was made to perform a transcatheter valve-in-valve procedure with a 29mm sapien valve.It was then reported two and a half years post-intervention, the patient developed recurrent bacterial endocarditis.A decision was made to surgically remove both 33mm epic valve with the embedded 29mm sapien valve.A 33mm epic plus valve was then implanted with no adverse patient consequences.The article concluded that mitral valve-in-valve explant is technically feasible.The authors recommended en bloc removal of both valves as the safest method of valve explant.[the primary and corresponding author was mohammad bashir, university of iowa carver college of medicine, department of cardiothoracic surgery, iowa city, iowa 52242, with corresponding email: mohammad-bashir@uiowa.Edu].
|
As reported in a research article, transcatheter mitral valve-in-valve explant: lessons learned.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|